Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
Svendsen
U G
UG
Rigshospitalet, National University Hospital, Copenhagen, Denmark.
Larsen
K R
KR
Allermand
H
H
Thayssen
P
P
Jensen
S B
SB
Pettersson
G
G
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004304:Dosage Forms; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology*; D016041:Heart-Lung Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000276:immunology*; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine